DK1007067T3 - Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ... - Google Patents

Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ...

Info

Publication number
DK1007067T3
DK1007067T3 DK97944746T DK97944746T DK1007067T3 DK 1007067 T3 DK1007067 T3 DK 1007067T3 DK 97944746 T DK97944746 T DK 97944746T DK 97944746 T DK97944746 T DK 97944746T DK 1007067 T3 DK1007067 T3 DK 1007067T3
Authority
DK
Denmark
Prior art keywords
extract
parts
manufacture
plant material
pharmaceutical preparations
Prior art date
Application number
DK97944746T
Other languages
English (en)
Inventor
Morten Sloth Weidner
A S Eurovita
Original Assignee
Eurovita As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurovita As filed Critical Eurovita As
Application granted granted Critical
Publication of DK1007067T3 publication Critical patent/DK1007067T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK97944746T 1996-10-21 1997-10-20 Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ... DK1007067T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK115896 1996-10-21
US3139596P 1996-11-19 1996-11-19
PCT/DK1997/000457 WO1998017292A1 (en) 1996-10-21 1997-10-20 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium

Publications (1)

Publication Number Publication Date
DK1007067T3 true DK1007067T3 (da) 2002-05-06

Family

ID=26065310

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97944746T DK1007067T3 (da) 1996-10-21 1997-10-20 Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ...

Country Status (10)

Country Link
US (1) US6217877B1 (da)
EP (1) EP1007067B1 (da)
JP (1) JP4346685B2 (da)
AT (1) ATE211918T1 (da)
AU (1) AU711019B2 (da)
DE (1) DE69709691T2 (da)
DK (1) DK1007067T3 (da)
ES (1) ES2172006T3 (da)
PT (1) PT1007067E (da)
WO (1) WO1998017292A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277978B1 (en) 1995-12-22 2001-08-21 University Of Utah Research Foundation KVLQT1—a long QT syndrome gene
ATE306263T1 (de) * 1999-03-10 2005-10-15 Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
US20010024664A1 (en) * 1999-03-19 2001-09-27 Obukowicz Mark G. Selective COX-2 inhibition from edible plant extracts
CO5190664A1 (es) 1999-06-30 2002-08-29 Pfizer Prod Inc Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
KR100793668B1 (ko) 1999-12-08 2008-01-10 파마시아 코포레이션 강화된 생체이용률을 지닌 고체상 형태의 셀레콕시브
AU2001285334A1 (en) 2000-08-29 2002-03-13 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
WO2002047706A2 (en) * 2000-12-15 2002-06-20 Pharmacia Corporation Selective cox-2 inhibition from plant extracts
US7758582B2 (en) * 2002-06-14 2010-07-20 Smith & Nephew, Inc. Device and methods for placing external fixation elements
US20040086579A1 (en) * 2002-11-05 2004-05-06 Higgins James W. Dietary supplement comprising parthenolide
US7192614B2 (en) 2002-11-05 2007-03-20 Gelstat Corporation Compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
TWI344959B (en) * 2003-04-02 2011-07-11 Nat Health Research Institutes Treatment of hepatitis c virus infection with sesquiterpene lactones
US20040247705A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal compositions and methods of treatment to alleviate or prevent migrainous headaches and their associated symptoms
US20040247706A1 (en) * 2003-06-06 2004-12-09 Roberts Stephen C. Transdermal dietary supplement comprising parthenolide
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
US9028852B2 (en) * 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US20060051384A1 (en) * 2004-09-07 2006-03-09 3M Innovative Properties Company Antiseptic compositions and methods of use
EP1829874B1 (en) * 2004-12-22 2014-02-12 Ono Pharmaceutical Co., Ltd. Tricyclic compound and use thereof
WO2006099325A2 (en) * 2005-03-10 2006-09-21 3M Innovative Properties Company Methods of treating ear infections
BRPI0608690B8 (pt) * 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
BRPI0608691A2 (pt) * 2005-03-10 2010-12-07 3M Innovative Properties Company composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
JP5031827B2 (ja) * 2006-06-01 2012-09-26 程云 予防或いは肝損傷を治療するペプチッド
CN104721602A (zh) * 2013-12-19 2015-06-24 汤丽娟 一种治疗腹型偏头痛的中药
CN113616747B (zh) * 2021-05-20 2023-03-24 天津中医药大学 一种感染性疾病康复用的中药组合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4058594A (en) * 1974-04-25 1977-11-15 John Williams Immuno-suppressive agents
CA1270843A (en) * 1982-05-19 1990-06-26 Edward Stewart Johnson Sesquiterpene lactones
DE3638715A1 (de) * 1986-11-13 1988-05-26 Lohmann Rudolf Lomapharm Sesquiterpenverbindungen, verfahren zu ihrer isolierung und arzneimittel, enthaltend diese verbindungen
US5053387A (en) * 1987-02-20 1991-10-01 Shriners Hospitals For Crippled Children Omega-3 fatty acids in traumatic injury treatment
US5055297A (en) * 1987-03-27 1991-10-08 Tsumura Juntendo Immunopotentiator

Also Published As

Publication number Publication date
EP1007067B1 (en) 2002-01-16
DE69709691T2 (de) 2002-08-22
WO1998017292A1 (en) 1998-04-30
PT1007067E (pt) 2002-07-31
ES2172006T3 (es) 2002-09-16
ATE211918T1 (de) 2002-02-15
DE69709691D1 (de) 2002-02-21
AU711019B2 (en) 1999-10-07
US6217877B1 (en) 2001-04-17
JP2001501919A (ja) 2001-02-13
JP4346685B2 (ja) 2009-10-21
EP1007067A1 (en) 2000-06-14
AU4615897A (en) 1998-05-15

Similar Documents

Publication Publication Date Title
DK1007067T3 (da) Farmaceutiske præparater indeholdende Parthenium integrifolium eller dele deraf eller en ekstrakt bestanddel deraf, anvendelsen af et sådant plantemateriale til fremstilling af ...
FR2751878B1 (fr) Utilisation dans une composition d'un extrait d'au moins une labiee
DE69730038D1 (de) Lösliche monovalente und multivalente mhc klasse ii fusionsproteine und deren verwendungen
NO972315D0 (no) Aerogelholdig komposittmateriale, fremgangsmåte for fremstilling derav samt anvendelse av materialet
DK0760848T3 (da) Lactobacillusstammer af menneskelig oprindelse, deres sammensætninger og anvendelse deraf
FI972431A7 (fi) Sytotoksisten T-lymfosyyttivasteiden induktio
EE9800080A (et) (Metüülsulfonüül)fenüül-2-(5H)-furanoonid, nende kasutamine ja farmatseutilised kompositsioonid
IL112778A0 (en) Substituted heterocycles, their preparation and pharmaceutical compositions containing them
ATE390917T1 (de) Prävention und behandlung von skeletterkrankungen mit ep2 subtyp selektiven prostaglandin e2 agonisten
NO831163L (no) N-glykosylerte karboksylsyreamidderivater, fremgangsmaater til deres fremstilling samt deres anvendelse til paavirkning av kroppens forsvarsmekanisme
DE69735482D1 (de) Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
EP0173092A3 (en) Anti viral composition
BG102891A (en) Enzymic pregranulate for fodder granulate
FI972413A0 (fi) Kosmeettinen kaoliinipitoinen valmiste
FR2753911B1 (fr) Procede de preparation d'une composition antimousse encapsulee, et composition ainsi preparee
ATE69727T1 (de) Zusammensetzung zur behandlung von an haemophilia- a-inhibitor leidenden kranken.
IL126998A (en) Potassium, sodium or tris oxaprozin salt pharmaceutical formulations
MD1521F2 (en) Methods of thrombus forming inhibition, methods of treatment of thrombotic states, pharmaceutical compositions and kit for treatment of thrombotic states
IL120151A (en) Solid biocontrol formulation containing azadirachtin
HU0102043D0 (en) Pharmaceutical compounds which interact with an ca2+ channel alpha2delta subunit
BG101959A (bg) Рекомбинантни предуоденални липази и полипептиднипроизводни, продуцирани от растения, метод за получаването и използването им
BG104373A (en) Polymorphous forms of dofetilide
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
BG102937A (en) Zona pelucida proteins as contraceptives